Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Public perspectives on supervised consumption sites across Canada

A cross-sectional study

Bibliographic Data

ID21594797
AuthorsWilliam Rioux (0000-0003-4278-9751, University of Alberta, corresponding author), Nathan Rider (0009-0003-2424-6005, University of Calgary), Boogyung Seo (0000-0002-0016-2355, University of Alberta), Dylan Viste (0000-0002-5340-2682, University of Calgary), Bo Pan (0009-0009-4561-2469, University of Alberta), Yazid Al Hamarneh (University of Alberta), S Monty Ghosh (0000-0002-1566-0015, University of Alberta)
Year2026
Volume155
Pages105411
Publication date2026-09-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Drug Policy (JOURNAL)
Journal identifiersISSN: 0955-3959 • E-ISSN: 1873-4758
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2026.105411
PMID42349281
OpenAlexW7165927124
LanguageEN
References cited40

INTRODUCTION: Canada continues to face high rates of drug poisoning, prompting the implementation of harm reduction measures, including supervised consumption sites (SCS). SCS remain politically and socially contested despite evidence supporting their effectiveness. Given recent debates on SCS operations and limited national data on public perceptions of them, this study examined data from a large bilingual pan-Canadian survey to assess attitudes of the general public towards SCS. METHODS: This study utilized data from a national online cross-sectional survey, the Canadian National Questionnaire on Overdose Monitoring (CNQOM). Likert-based questionnaire items evaluated public perceptions of SCS elements. The study examined the general public's perspectives towards SCS client considerations (e.g. safety), community impacts (e.g. discarded needles), and health system impacts (e.g. use of emergency services). CNQOM data was analyzed using the Wilcoxon Signed Rank Test. RESULTS: Between July 2022 and May 2023, out of 2866 valid participants, the general public perceived SCSs to have positive impacts on overdose and infection risk, improved access to healthcare, harm reduction, and social services. Respondents perceived SCS as effective in increasing education and awareness, particularly for people who use substances (PWUS), and viewed these services as appropriate across diverse populations and settings, including rural areas and acute care. Respondents felt SCSs reduced public drug use and discarded needles, but perceptions of broader community effects such as crime, public safety, and property values trended to be more neutral. Similarly, participants viewed SCS as enhancing safety for healthcare providers with neutral effects of healthcare system use and provider burnout. CONCLUSION: Members of the general public generally perceived SCS as beneficial for clients. Furthermore, participants did not identify SCS as having negative impacts on communities or health systems overall. Governments should consider these findings when making decisions about implementing SCS, modifying services, or closing SCS in their jurisdictions. Our findings are informative for harm reduction program planning and policy development at the national and provincial or state levels

Poison control · Public health · Suicide prevention · Focus Groups and Qualitative Methods · Human Factors and Ergonomics · Social and Cultural Dynamics · Survey Methodology and Nonresponse

  • Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility

    Open Access•Brandon D L Marshall, Brandon DL Marshall et al.•The Lancet•2011

  • Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities

    Open Access•Mary Clare Kennedy, Mohammad Karamouzian et al.•Current HIV/AIDS Reports•2017

  • Supervised Injection Facilities as Harm Reduction

    Open Access•Timothy W Levengood, Grace H Yoon et al.•American Journal of Preventive…•2021

  • Improving the Quality of Web Surveys

    Open Access•Gunther Eysenbach•Journal of Medical Internet…•2004

  • Responding to the opioid crisis in North America and beyond

    Open Access•Keith Humphreys, Chelsea L Shover et al.•The Lancet•2022

  • Risk creating and risk reducing

    Gillian Kolla, Carol Strike et al.•Health Risk & Society•2017

  • Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France

    Open Access•Marie Jauffret‐roustide, Cécile Donadille et al.•International Journal of…•2022

  • Spatial-temporal trends in the risk of illicit drug toxicity death in British Columbia

    Open Access•Kevin Hu, Brian Klinkenberg et al.•BMC Public Health•2022

  • Determinants of hospitalization for a cutaneous injection-related infection among injection drug users

    Open Access•Elisa Lloyd‐Smith, Elisa Lloyd-Smith et al.•BMC Public Health•2010

  • Virtual overdose monitoring services and overdose prevention technologies

    Open Access•William Rioux, Tyler Marshall et al.•International Journal of Drug…•2023

  • The prospect of implementing a Safer Injection Facility in San Francisco

    Open Access•Lynn D Wenger, Sonya Arreola et al.•International Journal of Drug…•2011

  • Assessing support for supervised injection services among community stakeholders in London, Canada

    Open Access•Geoff Bardwell, Ayden I Scheim et al.•International Journal of Drug…•2017

  • Changes in public order after the opening of an overdose monitoring facility for people who inject drugs

    Open Access•Casey León, Lena J P Cardoso et al.•International Journal of Drug…•2018

  • Canadian harm reduction policies

    Open Access•T Cameron Wild, Bernie Pauly et al.•International Journal of Drug…•2017

  • A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility

    Open Access•M A Andresen, Neil Boyd et al.•International Journal of Drug…•2010

  • Covid-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services

    Open Access•Melissa Perri, Ruth A Schmidt et al.•International Journal of Drug…•2022

  • Flawed reports can harm

    Open Access•Ginetta Salvalaggio, Hannah L Brooks et al.•Canadian Journal of Public Health•2023

Citation velocityhistorical
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae